FCCC, Inc./ US30246C1045 /
31/05/2024 17:59:21 | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.2500USD | - | 1,700 Turnover: 425 |
-Bid Size: - | -Ask Size: - | 0.2500 | 0.2500 |
GlobeNewswire
03/06
ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet...
GlobeNewswire
06/05
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire
08/04
ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iad...
GlobeNewswire
26/02
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
GlobeNewswire
05/02
ORYZON to Provide Corporate Progress Updates at Several Events in February-March
GlobeNewswire
21/11/2023
ORYZON Announces a New Financing Through a Convertible Bond Program For a Total Amount of Up To €45 ...
GlobeNewswire
27/10/2023
ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023
GlobeNewswire
08/03/2022
UPDATE -- Media Advisory: To Address Increase in Demand for Sustainable Flexible Packaging, Glenroy ...
GlobeNewswire
08/03/2022
Media Advisory: To Address Increase in Demand for Sustainable Flexible Packaging, Glenroy Inc. Annou...
GlobeNewswire
01/12/2021
TimelyMD Partners with Foundation for California Community Colleges to Provide Students 24/7 Telehea...
GlobeNewswire
22/09/2021
Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership
GlobeNewswire
15/07/2021
Abel Noser Solutions and J.P. Morgan Collaborate to Provide Flexible, End-to-End TCA Solution
GlobeNewswire
13/07/2021
Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatmen...